HOD Journal

Hematology and Oncology Discovery
  • Home
  • About
    • Background
    • Editorial Board
    • Aims & Scope
    • Peer Review
    • Publication Ethics and Malpractice Statement
    • Archiving
    • Copyright and Permissions
    • Ownership
    • Advertising
    • Privacy Policy
    • Initiative for Open Citations
  • For Authors
    • Submit a Paper
    • Instructions to Authors
    • Peer Review
    • Article Types
    • Submission Process
    • Copyright and Permissions
    • Author Self-Archiving Policy
    • Article Retraction
    • Archiving
  • FAQs
  • Archives
  • Contact Us

Advertising

Hematology and Oncology Discovery accepts advertisements. Please contact the editorial office E-mail:  editorialoffice@HOD-journal.org for further information.

Publication Information

Hematology and Oncology Discovery launched in 2022; the journal has a continuous article publication process.

Co-Editors-in-Chief

Dong Chen, MD, PhD, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Lugui Qiu, MD, Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Executive Editor-in-Chief

Tong Wu, MD, Beijing Boren Hospital, Beijing, China

Upcoming Special Issues

Upcoming special issue topics include:

CAR-T Cell Therapy For Hematology

Lymphoma

Integrative Diagnosis for Hematology Diseases

Indexing

Submit Your Article

Subscribe to Our TOC Alerts

Check your inbox or spam folder to confirm your subscription.

Call for Papers

CAR-T Cell Therapy For Hematology

HOD Journal © 2022 Frontier Theme